Recently, our previous study and another Canadian study demonstrated that children in VHL families presented manifestations more than 10 years earlier than their parents, suggesting that surveillance plan for children should not only consider the regular VHL tumor surveillance regimen, but also the onset age of their parents (Ning et al., 2014; Aronoff et al., 2018). The gene discussed is VHL; the disease is von Hippel-Lindau disease.